Two Sigma Advisers’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Sell |
485,700
-19,900
| -4% | -$21.1K | ﹤0.01% | 1735 |
|
|
2025
Q1 | $551K | Sell |
505,600
-209,000
| -29% | -$228K | ﹤0.01% | 1736 |
|
|
2024
Q4 | $1.08M | Sell |
714,600
-36,600
| -5% | -$55.3K | ﹤0.01% | 1422 |
|
|
2024
Q3 | $1.12M | Buy |
751,200
+257,700
| +52% | +$384K | ﹤0.01% | 1363 |
|
|
2024
Q2 | $799K | Buy |
493,500
+128,100
| +35% | +$208K | ﹤0.01% | 1669 |
|
|
2024
Q1 | $621K | Buy |
365,400
+176,800
| +94% | +$301K | ﹤0.01% | 1777 |
|
|
2023
Q4 | $585K | Buy |
188,600
+149,800
| +386% | +$464K | ﹤0.01% | 1854 |
|
|
2023
Q3 | $238K | Sell |
38,800
-63,900
| -62% | -$392K | ﹤0.01% | 2052 |
|
|
2023
Q2 | $643K | Buy |
102,700
+47,800
| +87% | +$299K | ﹤0.01% | 1714 |
|
|
2023
Q1 | $262K | Buy |
+54,900
| New | +$262K | ﹤0.01% | 2189 |
|
|
2022
Q2 | – | Sell |
-28,100
| Closed | -$585K | – | 2836 |
|
|
2022
Q1 | $585K | Sell |
28,100
-6,400
| -19% | -$133K | ﹤0.01% | 1906 |
|
|
2021
Q4 | $797K | Buy |
+34,500
| New | +$797K | ﹤0.01% | 1683 |
|